Cite

HARVARD Citation

    Ujjani, C. et al. (2022). Heterologous SARS‐CoV‐2 vaccinations in patients with B‐cell lymphoid malignancies. American journal of hematology. 97 (2), pp. E67-E69. [Online]. 
  
Back to record